Saving U.S. Manufacturing: Think Biotech, Not Cars

By KIM BELLARD Amidst all the drama last week with tariffs, trade wars, and market upheavals, you may have missed that the National Security Commission on Emerging Biotechnology (NSCEB) issued its report: Charting the Future of Biotechnology. Indeed, you may have missed when the Commission was created by Congress in 2022; I know I did….

Read More

Denial prevention: Why manage denials when you can prevent them?

The denial challenge is getting tougher. In Experian Health’s latest State of Claims 2024 survey, almost three-quarters of healthcare administrators agree that claim denials are increasing. The majority also agree that difficulties with claims—like reimbursement times, errors, and payer policy changes—are becoming more common. It’s no surprise that denial prevention is a priority for 84% of respondents….

Read More

Deal or No Deal? States Prepare for Congress To Act at the Last Minute on Obamacare

Saturday is the day that nearly 24 million customers can start purchasing health plans on healthcare.gov and the state-run Obamacare exchanges.  Higher prices and uncertainty await many of those shoppers.  Average premiums are expected to more than double. The directors who manage marketplace enrollment in states including Maryland, California, Pennsylvania, and Idaho told me and my colleague Julie Appleby that people are wondering how they’ll scrape together hundreds — or even thousands — of dollars more next year to pay for these…

Read More

Nourish Secures $100M for Metabolic Health Clinic

Nourish’s Series C round was led by Menlo Ventures, with participation from Thrive Capital, Index Ventures, J.P. Morgan Growth Equity Partners, Maverick Ventures, Y Combinator, BoxGroup, Atomico, Daybreak and Operator Partners. The post Nourish Secures $100M for Metabolic Health Clinic appeared first on MedCity News.

Read More